Donald Trump rejects Biden's proposal for Medicare coverage of high-demand obesity drugs

Hindustan Times

Hindustan Times

Summary

88:88
President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk 's Wegovy and Eli Lilly 's Zepbound.
CNBC
88:88
The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden administration unveiled in November.
CNN
88:88
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
The New York Times
88:88
U.S.-listed shares of Novo fell 2% in aftermarket trading, while those of Eli Lilly, which makes obesity drug Zepbound, were down 1.6%.
Newsmax

■ Story #21 ▪

issue 88:88 ▪

23 items ▪

12 sources ▪

updated 88:88

Posts

Frontpage